Report Overview
Japanese meningitis vaccine is a vaccine used to prevent Japanese encephalitis, and vaccination against Japanese encephalitis is an effective measure to prevent Japanese encephalitis.
The global Meningitis B Vaccine market size was estimated at USD 23630 million in 2023 and is projected to reach USD 30563.43 million by 2032, exhibiting a CAGR of 2.90% during the forecast period.
North America Meningitis B Vaccine market size was estimated at USD 6467.21 million in 2023, at a CAGR of 2.49% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Meningitis B Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Meningitis B Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Meningitis B Vaccine market in any manner.
Global Meningitis B Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
GlaxoSmithKline
Novartis
BEXSERO
TRUMENBA
Pfizer
Sanofi Pasteur Inc
Wyeth Pharmaceuticals
Inc.
Market Segmentation (by Type)
MenACWY (Conjugate) Vaccine
MenB (Recombinant Protein) Vaccine
Market Segmentation (by Application)
Hospital
Clinic
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Meningitis B Vaccine Market
Overview of the regional outlook of the Meningitis B Vaccine Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter�s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Meningitis B Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Meningitis B Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Meningitis B Vaccine
1.2 Key Market Segments
1.2.1 Meningitis B Vaccine Segment by Type
1.2.2 Meningitis B Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Meningitis B Vaccine Market Overview
2.1 Global Market Overview
2.1.1 Global Meningitis B Vaccine Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Meningitis B Vaccine Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Meningitis B Vaccine Market Competitive Landscape
3.1 Global Meningitis B Vaccine Sales by Manufacturers (2019-2025)
3.2 Global Meningitis B Vaccine Revenue Market Share by Manufacturers (2019-2025)
3.3 Meningitis B Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Meningitis B Vaccine Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Meningitis B Vaccine Sales Sites, Area Served, Product Type
3.6 Meningitis B Vaccine Market Competitive Situation and Trends
3.6.1 Meningitis B Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Meningitis B Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Meningitis B Vaccine Industry Chain Analysis
4.1 Meningitis B Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Meningitis B Vaccine Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Meningitis B Vaccine Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Meningitis B Vaccine Sales Market Share by Type (2019-2025)
6.3 Global Meningitis B Vaccine Market Size Market Share by Type (2019-2025)
6.4 Global Meningitis B Vaccine Price by Type (2019-2025)
7 Meningitis B Vaccine Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Meningitis B Vaccine Market Sales by Application (2019-2025)
7.3 Global Meningitis B Vaccine Market Size (M USD) by Application (2019-2025)
7.4 Global Meningitis B Vaccine Sales Growth Rate by Application (2019-2025)
8 Meningitis B Vaccine Market Consumption by Region
8.1 Global Meningitis B Vaccine Sales by Region
8.1.1 Global Meningitis B Vaccine Sales by Region
8.1.2 Global Meningitis B Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Meningitis B Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Meningitis B Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Meningitis B Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Meningitis B Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Meningitis B Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Meningitis B Vaccine Market Production by Region
9.1 Global Production of Meningitis B Vaccine by Region (2019-2025)
9.2 Global Meningitis B Vaccine Revenue Market Share by Region (2019-2025)
9.3 Global Meningitis B Vaccine Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Meningitis B Vaccine Production
9.4.1 North America Meningitis B Vaccine Production Growth Rate (2019-2025)
9.4.2 North America Meningitis B Vaccine Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Meningitis B Vaccine Production
9.5.1 Europe Meningitis B Vaccine Production Growth Rate (2019-2025)
9.5.2 Europe Meningitis B Vaccine Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Meningitis B Vaccine Production (2019-2025)
9.6.1 Japan Meningitis B Vaccine Production Growth Rate (2019-2025)
9.6.2 Japan Meningitis B Vaccine Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Meningitis B Vaccine Production (2019-2025)
9.7.1 China Meningitis B Vaccine Production Growth Rate (2019-2025)
9.7.2 China Meningitis B Vaccine Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 GlaxoSmithKline
10.1.1 GlaxoSmithKline Meningitis B Vaccine Basic Information
10.1.2 GlaxoSmithKline Meningitis B Vaccine Product Overview
10.1.3 GlaxoSmithKline Meningitis B Vaccine Product Market Performance
10.1.4 GlaxoSmithKline Business Overview
10.1.5 GlaxoSmithKline Meningitis B Vaccine SWOT Analysis
10.1.6 GlaxoSmithKline Recent Developments
10.2 Novartis
10.2.1 Novartis Meningitis B Vaccine Basic Information
10.2.2 Novartis Meningitis B Vaccine Product Overview
10.2.3 Novartis Meningitis B Vaccine Product Market Performance
10.2.4 Novartis Business Overview
10.2.5 Novartis Meningitis B Vaccine SWOT Analysis
10.2.6 Novartis Recent Developments
10.3 BEXSERO
10.3.1 BEXSERO Meningitis B Vaccine Basic Information
10.3.2 BEXSERO Meningitis B Vaccine Product Overview
10.3.3 BEXSERO Meningitis B Vaccine Product Market Performance
10.3.4 BEXSERO Meningitis B Vaccine SWOT Analysis
10.3.5 BEXSERO Business Overview
10.3.6 BEXSERO Recent Developments
10.4 TRUMENBA
10.4.1 TRUMENBA Meningitis B Vaccine Basic Information
10.4.2 TRUMENBA Meningitis B Vaccine Product Overview
10.4.3 TRUMENBA Meningitis B Vaccine Product Market Performance
10.4.4 TRUMENBA Business Overview
10.4.5 TRUMENBA Recent Developments
10.5 Pfizer
10.5.1 Pfizer Meningitis B Vaccine Basic Information
10.5.2 Pfizer Meningitis B Vaccine Product Overview
10.5.3 Pfizer Meningitis B Vaccine Product Market Performance
10.5.4 Pfizer Business Overview
10.5.5 Pfizer Recent Developments
10.6 Sanofi Pasteur Inc
10.6.1 Sanofi Pasteur Inc Meningitis B Vaccine Basic Information
10.6.2 Sanofi Pasteur Inc Meningitis B Vaccine Product Overview
10.6.3 Sanofi Pasteur Inc Meningitis B Vaccine Product Market Performance
10.6.4 Sanofi Pasteur Inc Business Overview
10.6.5 Sanofi Pasteur Inc Recent Developments
10.7 Wyeth Pharmaceuticals
10.7.1 Wyeth Pharmaceuticals Meningitis B Vaccine Basic Information
10.7.2 Wyeth Pharmaceuticals Meningitis B Vaccine Product Overview
10.7.3 Wyeth Pharmaceuticals Meningitis B Vaccine Product Market Performance
10.7.4 Wyeth Pharmaceuticals Business Overview
10.7.5 Wyeth Pharmaceuticals Recent Developments
10.8 Inc.
10.8.1 Inc. Meningitis B Vaccine Basic Information
10.8.2 Inc. Meningitis B Vaccine Product Overview
10.8.3 Inc. Meningitis B Vaccine Product Market Performance
10.8.4 Inc. Business Overview
10.8.5 Inc. Recent Developments
11 Meningitis B Vaccine Market Forecast by Region
11.1 Global Meningitis B Vaccine Market Size Forecast
11.2 Global Meningitis B Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Meningitis B Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Meningitis B Vaccine Market Size Forecast by Region
11.2.4 South America Meningitis B Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Meningitis B Vaccine by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Meningitis B Vaccine Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Meningitis B Vaccine by Type (2025-2032)
12.1.2 Global Meningitis B Vaccine Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Meningitis B Vaccine by Type (2025-2032)
12.2 Global Meningitis B Vaccine Market Forecast by Application (2025-2032)
12.2.1 Global Meningitis B Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Meningitis B Vaccine Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Meningitis B Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Meningitis B Vaccine Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Meningitis B Vaccine Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Meningitis B Vaccine Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Meningitis B Vaccine Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningitis B Vaccine as of 2022)
Table 10. Global Market Meningitis B Vaccine Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Meningitis B Vaccine Sales Sites and Area Served
Table 12. Manufacturers Meningitis B Vaccine Product Type
Table 13. Global Meningitis B Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Meningitis B Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Meningitis B Vaccine Market Challenges
Table 22. Global Meningitis B Vaccine Sales by Type (K MT)
Table 23. Global Meningitis B Vaccine Market Size by Type (M USD)
Table 24. Global Meningitis B Vaccine Sales (K MT) by Type (2019-2025)
Table 25. Global Meningitis B Vaccine Sales Market Share by Type (2019-2025)
Table 26. Global Meningitis B Vaccine Market Size (M USD) by Type (2019-2025)
Table 27. Global Meningitis B Vaccine Market Size Share by Type (2019-2025)
Table 28. Global Meningitis B Vaccine Price (USD/MT) by Type (2019-2025)
Table 29. Global Meningitis B Vaccine Sales (K MT) by Application
Table 30. Global Meningitis B Vaccine Market Size by Application
Table 31. Global Meningitis B Vaccine Sales by Application (2019-2025) & (K MT)
Table 32. Global Meningitis B Vaccine Sales Market Share by Application (2019-2025)
Table 33. Global Meningitis B Vaccine Sales by Application (2019-2025) & (M USD)
Table 34. Global Meningitis B Vaccine Market Share by Application (2019-2025)
Table 35. Global Meningitis B Vaccine Sales Growth Rate by Application (2019-2025)
Table 36. Global Meningitis B Vaccine Sales by Region (2019-2025) & (K MT)
Table 37. Global Meningitis B Vaccine Sales Market Share by Region (2019-2025)
Table 38. North America Meningitis B Vaccine Sales by Country (2019-2025) & (K MT)
Table 39. Europe Meningitis B Vaccine Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Meningitis B Vaccine Sales by Region (2019-2025) & (K MT)
Table 41. South America Meningitis B Vaccine Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Meningitis B Vaccine Sales by Region (2019-2025) & (K MT)
Table 43. Global Meningitis B Vaccine Production (K MT) by Region (2019-2025)
Table 44. Global Meningitis B Vaccine Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Meningitis B Vaccine Revenue Market Share by Region (2019-2025)
Table 46. Global Meningitis B Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Meningitis B Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Meningitis B Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Meningitis B Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Meningitis B Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. GlaxoSmithKline Meningitis B Vaccine Basic Information
Table 52. GlaxoSmithKline Meningitis B Vaccine Product Overview
Table 53. GlaxoSmithKline Meningitis B Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. GlaxoSmithKline Business Overview
Table 55. GlaxoSmithKline Meningitis B Vaccine SWOT Analysis
Table 56. GlaxoSmithKline Recent Developments
Table 57. Novartis Meningitis B Vaccine Basic Information
Table 58. Novartis Meningitis B Vaccine Product Overview
Table 59. Novartis Meningitis B Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. Novartis Business Overview
Table 61. Novartis Meningitis B Vaccine SWOT Analysis
Table 62. Novartis Recent Developments
Table 63. BEXSERO Meningitis B Vaccine Basic Information
Table 64. BEXSERO Meningitis B Vaccine Product Overview
Table 65. BEXSERO Meningitis B Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. BEXSERO Meningitis B Vaccine SWOT Analysis
Table 67. BEXSERO Business Overview
Table 68. BEXSERO Recent Developments
Table 69. TRUMENBA Meningitis B Vaccine Basic Information
Table 70. TRUMENBA Meningitis B Vaccine Product Overview
Table 71. TRUMENBA Meningitis B Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. TRUMENBA Business Overview
Table 73. TRUMENBA Recent Developments
Table 74. Pfizer Meningitis B Vaccine Basic Information
Table 75. Pfizer Meningitis B Vaccine Product Overview
Table 76. Pfizer Meningitis B Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. Pfizer Business Overview
Table 78. Pfizer Recent Developments
Table 79. Sanofi Pasteur Inc Meningitis B Vaccine Basic Information
Table 80. Sanofi Pasteur Inc Meningitis B Vaccine Product Overview
Table 81. Sanofi Pasteur Inc Meningitis B Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. Sanofi Pasteur Inc Business Overview
Table 83. Sanofi Pasteur Inc Recent Developments
Table 84. Wyeth Pharmaceuticals Meningitis B Vaccine Basic Information
Table 85. Wyeth Pharmaceuticals Meningitis B Vaccine Product Overview
Table 86. Wyeth Pharmaceuticals Meningitis B Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 87. Wyeth Pharmaceuticals Business Overview
Table 88. Wyeth Pharmaceuticals Recent Developments
Table 89. Inc. Meningitis B Vaccine Basic Information
Table 90. Inc. Meningitis B Vaccine Product Overview
Table 91. Inc. Meningitis B Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 92. Inc. Business Overview
Table 93. Inc. Recent Developments
Table 94. Global Meningitis B Vaccine Sales Forecast by Region (2025-2032) & (K MT)
Table 95. Global Meningitis B Vaccine Market Size Forecast by Region (2025-2032) & (M USD)
Table 96. North America Meningitis B Vaccine Sales Forecast by Country (2025-2032) & (K MT)
Table 97. North America Meningitis B Vaccine Market Size Forecast by Country (2025-2032) & (M USD)
Table 98. Europe Meningitis B Vaccine Sales Forecast by Country (2025-2032) & (K MT)
Table 99. Europe Meningitis B Vaccine Market Size Forecast by Country (2025-2032) & (M USD)
Table 100. Asia Pacific Meningitis B Vaccine Sales Forecast by Region (2025-2032) & (K MT)
Table 101. Asia Pacific Meningitis B Vaccine Market Size Forecast by Region (2025-2032) & (M USD)
Table 102. South America Meningitis B Vaccine Sales Forecast by Country (2025-2032) & (K MT)
Table 103. South America Meningitis B Vaccine Market Size Forecast by Country (2025-2032) & (M USD)
Table 104. Middle East and Africa Meningitis B Vaccine Consumption Forecast by Country (2025-2032) & (Units)
Table 105. Middle East and Africa Meningitis B Vaccine Market Size Forecast by Country (2025-2032) & (M USD)
Table 106. Global Meningitis B Vaccine Sales Forecast by Type (2025-2032) & (K MT)
Table 107. Global Meningitis B Vaccine Market Size Forecast by Type (2025-2032) & (M USD)
Table 108. Global Meningitis B Vaccine Price Forecast by Type (2025-2032) & (USD/MT)
Table 109. Global Meningitis B Vaccine Sales (K MT) Forecast by Application (2025-2032)
Table 110. Global Meningitis B Vaccine Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Meningitis B Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Meningitis B Vaccine Market Size (M USD), 2019-2032
Figure 5. Global Meningitis B Vaccine Market Size (M USD) (2019-2032)
Figure 6. Global Meningitis B Vaccine Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Meningitis B Vaccine Market Size by Country (M USD)
Figure 11. Meningitis B Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Meningitis B Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Meningitis B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Meningitis B Vaccine Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Meningitis B Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Meningitis B Vaccine Market Share by Type
Figure 18. Sales Market Share of Meningitis B Vaccine by Type (2019-2025)
Figure 19. Sales Market Share of Meningitis B Vaccine by Type in 2023
Figure 20. Market Size Share of Meningitis B Vaccine by Type (2019-2025)
Figure 21. Market Size Market Share of Meningitis B Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Meningitis B Vaccine Market Share by Application
Figure 24. Global Meningitis B Vaccine Sales Market Share by Application (2019-2025)
Figure 25. Global Meningitis B Vaccine Sales Market Share by Application in 2023
Figure 26. Global Meningitis B Vaccine Market Share by Application (2019-2025)
Figure 27. Global Meningitis B Vaccine Market Share by Application in 2023
Figure 28. Global Meningitis B Vaccine Sales Growth Rate by Application (2019-2025)
Figure 29. Global Meningitis B Vaccine Sales Market Share by Region (2019-2025)
Figure 30. North America Meningitis B Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Meningitis B Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Meningitis B Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Meningitis B Vaccine Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Meningitis B Vaccine Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Meningitis B Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Meningitis B Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Meningitis B Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Meningitis B Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Meningitis B Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Meningitis B Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Meningitis B Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Meningitis B Vaccine Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Meningitis B Vaccine Sales Market Share by Region in 2023
Figure 44. China Meningitis B Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Meningitis B Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Meningitis B Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Meningitis B Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Meningitis B Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Meningitis B Vaccine Sales and Growth Rate (K MT)
Figure 50. South America Meningitis B Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Meningitis B Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Meningitis B Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Meningitis B Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Meningitis B Vaccine Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Meningitis B Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Meningitis B Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Meningitis B Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Meningitis B Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Meningitis B Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Meningitis B Vaccine Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Meningitis B Vaccine Production Market Share by Region (2019-2025)
Figure 62. North America Meningitis B Vaccine Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Meningitis B Vaccine Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Meningitis B Vaccine Production (K MT) Growth Rate (2019-2025)
Figure 65. China Meningitis B Vaccine Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Meningitis B Vaccine Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Meningitis B Vaccine Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Meningitis B Vaccine Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Meningitis B Vaccine Market Share Forecast by Type (2025-2032)
Figure 70. Global Meningitis B Vaccine Sales Forecast by Application (2025-2032)
Figure 71. Global Meningitis B Vaccine Market Share Forecast by Application (2025-2032)
